The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: BP boosted by lower-than-expected fine, ARM hit by Intel competition

Fri, 16th Jan 2015 12:53

Oil giant BP was among the risers after the company revealed it faces a maximum penalty of $13.7bn under the Clean Water Act. This follows the District Court for the Eastern District of Louisiana ruling on the Deepwater Horizon case, which found that 3.19m barrels of oil were discharged in the Gulf of Mexico in 2010. The bill, which was some $4bn less than feared, put the spill's size below the government's 4.09m estimate and just under the 3.26m estimated by the firm. Sector peer BHP Billiton was also up, after oil prices advanced on Friday morning. Brent futures were up 2.6% at $49.50 a barrel after the International Energy Agency (IEA) said a turnaround could be on the horizon. "A price recovery - barring any major disruption - may not be imminent, but signs are mounting that the tide will turn. A rebalancing may begin to occur in the second half of the year," the IEA said, as it lowered its forecasts for non-OPEC supply.Imperial Tobacco's share prices were boosted as Morgan Stanley hiked its target price from 2,680p to 3,250p and named the stock its new top pick, saying it is "increasingly optimistic" about its pending $7bn acquisition of assets from Reynolds and Lorillard.BT Group shares were also higher after being upgraded from 'hold' to 'buy' by Societe Generale.Meanwhile ARM Holdings took a hit after US chip rival Intel revealed it had sold more-than-expected chips for tablets in 2014 on Thursday night. Liberum kept a 'sell' rating on ARM, saying that competition from Intel is now rising in the smartphone sector, "which could take share from ARM in its core market".AstraZeneca was falling following a downgrade from Barclays Capital from 'equal weight' to 'underweight'. The broker said: "In an interview with The Times late last year CEO Pascal Soriot urged investors to not fixate on the Long-Range Plan central to its bid defence against Pfizer and to focus instead on margins. We view this as a tacit admission that management's $45 bn 2023 revenue projection is unrealistic and we view 2017 revenue guidance as equally unlikely to be met." RisersExperian (EXPN) 1,162.00p +3.66%Antofagasta (ANTO) 688.50p +2.76%BP (BP.) 403.40p +2.75%Glencore (GLEN) 247.05p +2.68%Anglo American (AAL) 1,087.00p +2.60%BG Group (BG.) 836.90p +2.01%BT Group (BT.A) 407.80p +1.90%BHP Billiton (BLT) 1,373.50p +1.89%Imperial Tobacco Group (IMT) 2,904.00p +1.89%Standard Life (SL.) 392.20p +1.24% FallerseasyJet (EZJ) 1,600.00p -2.74%Wolseley (WOS) 3,601.00p -2.54%Mondi (MNDI) 1,052.00p -2.41%Dixons Carphone (DC.) 424.30p -2.33%ARM Holdings (ARM) 974.00p -2.16%Babcock International Group (BAB) 1,003.00p -1.57%AstraZeneca (AZN) 4,661.50p -1.43%Burberry Group (BRBY) 1,661.00p -1.37%Persimmon (PSN) 1,436.00p -1.37%Meggitt (MGGT) 511.00p -1.35%
More News
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.